logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mark-David Levin

Albert Schweitzer Hospital
H指数:34
被引数:6,348

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

荷兰多发性骨髓瘤：35年发病率和生存趋势

Leukemia
IF13.4
2026-10-220
OAAI
Koen M. Klomberg; Wilfried W. H. Roeloffzen; Marcel Nijland; Mark-David Levin; Inger S. Nijhof; Rimke Oostvogels; Elizabeth de Kort; Ruth Wester; Catharina H. M. J. van Elssen; Esther G. M. de Waal; Paul A. F. Geerts; Yavuz M. Bilgin; Djamila E. Issa; Marjolein van de Klift; Gerwin A. Huls; Laurens E. Franssen; Cleo R. van Rooijen; Monique C. Minnema; Annemiek Broijl; Paula F. Ypma; Niels W. C. J. van de Donk; Sonja Zweegman; Mirian Brink; Wouter J. Plattel
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival

慢性淋巴细胞白血病的首选用药伊布替尼-维奈克拉组合：GLOW研究67个月结果及无3/4级不良事件的无进展生存期

Leukemia
IF13.4
2026-10-020
OAAI
Carsten U. Niemann; Talha Munir; Carolyn Owen; George Follows; José-Ángel Hernández-Rivas; Ohad Benjamini; Ann Janssens; Mark-David Levin; Tadeusz Robak; Martin Simkovic; Sergey Voloshin; Vladimir Vorobyev; Loic Ysebaert; Natasha Schuier; Kurt Baeten; Nguyet Tran; Bennett Levitan; Claire Kavanagh; Arnon P. Kater
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax

一种功能性预后模型预测接受伊布替尼联合维奈克拉治疗复发性慢性淋巴细胞白血病患者无进展生存期

HemaSphere
IF14.6
2026-09-180
OAAI
Johanne U. Hermansen; Weikaixin Kong; Andrea M. Brodersen; Yanping Yin; Aleksandra Urban; Idun D. Rein; Liye He; Rudi Agius; Rebecca S. Teglgaard; Juho Rousu; Christian Brieghel; Sabina Kersting; Mark-David Levin; Hoa T. T. Tran; Mattias Mattsson; Juha Ranti; Gerrit-Jan Veldhuis; Caspar da Cunha-Bang; Rogier Mous; Julie Dubois; Arnon P. Kater; Jorrit M. Enserink; Carsten U. Niemann; Tero Aittokallio; Sigrid S. Skånland
FDG-PET Medullary Total Tumor Volume Highlights High-Risk Newly Diagnosed Multiple Myeloma Patients in CASSIOPEIA Trial

FDG-PET骨髓总肿瘤体积在CASSIOPEIA试验中凸显高风险新诊断多发性骨髓瘤患者

Blood Advances
IF7.1
2026-03-310
OAAI
Bastien Jamet; Shamimeh Ahrari; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Diana Mateus; Philippe Moreau
Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome

揭示超脆弱人群：非移植适应症的 newly diagnosed 多发性骨髓瘤患者中的一个独特亚组，具有较差的临床结局

HemaSphere
IF14.6
2025-12-080
OAAI
Kazimierz Groen; Febe Smits; Kazem Nasserinejad; Mark-David Levin; Josien C. Regelink; Gert-Jan Timmers; Esther G. M. de Waal; Matthijs Westerman; Gerjo A. Velders; Koen de Heer; Rineke B. L. Leys; Roel J. W. van Kampen; Claudia A. M. Stege; Maarten R. Seefat; Inger S. Nijhof; Ellen van der Spek; Saskia K. Klein; Niels W. C. J. van de Donk; Paula F. Ypma; Sonja Zweegman
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

Al-Sawaf, O.; Stumpf, J.; Zhang, C.; Simon, F.; Bosch, F.; Feyzi, E.; Ghia, P.; Gregor, M.; Kater, A.P.; Lindström, V.; 等. 固定疗程与持续治疗在慢性淋巴细胞白血病中的应用比较. N. Engl. J. Med. 2025, 393, 24. [Google Scholar] [CrossRef]

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2025-12-018
PRE
Al-Sawaf, Othman; Stumpf, Janina; Zhang, Can; Simon, Florian; Bosch, Francesc; Feyzi, Emadoldin; Ghia, Paolo; Gregor, Michael; Kater, Arnon P.; Lindstrom, Vesa; Mattsson, Mattias; Niemann, Carsten U.; Staber, Philipp B.; Tadmor, Tamar; Thornton, Patrick; Wendtner, Clemens-Martin; Janssens, Ann; Noesslinger, Thomas; Bohn, Jan-Paul; da Cunha-Bang, Caspar; Poulsen, Christian B.; Ranti, Juha; Illmer, Thomas; Schoettker, Bjoern; Boettcher, Sebastian; Gaska, Tobias; Vandenberghe, Elisabeth; Clifford, Ruth; Benjamini, Ohad; Frustaci, Anna Maria; Scarfo, Lydia; Sportoletti, Paolo; Schreurs, John; Levin, Mark-David; van der Straaten, Hanneke; van der Klift, Marjolein; Tran, Hoa; de la Serna, Javier; Loscertales, Javier; Lindblad, Oscar; Sandstedt, Anna Bergendahl; Goede, Jeroen; Baumann, Michael; Fink, Anna Maria; Fischer, Kirsten; Ritgen, Matthias; Kreuzer, Karl-Anton; Schneider, Christof; Tausch, Eugen; Stilgenbauer, Stephan; Robrecht, Sandra; Eichhorst, Barbara; Hallek, Michael
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma

帕博利珠单抗替代给药方案在多发性骨髓瘤治疗中的药代动力学和药效动力学评价

British Journal of Haematology
IF3.8
2025-11-030
OAAI
M. R. Seefat; D. G. J. Cucchi; L. van Boven; N. Durdu-Rayman; K. Groen; M.-D. Levin; K. de Heer; B. de Valk; R. Wester; E. van der Spek; R. Rentenaar; C. L. B. M. Korst; M. Quik; C. A. O'Neill; P. Tzortzi; F. Smits; R. Mathot; M. R. Heerma van Voss; N. W. C. J. van de Donk; T. Mutis; I. H. Bartelink; S. Zweegman
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels

老年新诊断多发性骨髓瘤患者的免疫特征与一线治疗的生存结局相关，且与脆弱性水平无关。

HemaSphere
IF14.6
2025-10-050
OAAI
Wassilis S. C. Bruins; Febe Smits; Carolien Duetz; Kazem Nasserinejad; Kazimierz Groen; Charlotte L. B. M. Korst; A. Vera de Jonge; Rosa Rentenaar; Tamara Hageman; Meliha Cosovic; Merve Eken; Inoka Twickler; Paola M. Homan-Weert; Christie P. M. Verkleij; Kristine Frerichs; Mark-David Levin; Ellen van der Spek; Inger S. Nijhof; Roel van Kampen; Niels W. C. J. van de Donk; Sonja Zweegman; Tuna Mutis
Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study

皮下注射达雷木单抗联合卡非佐米和地塞米松（D-Kd）与卡非佐米和地塞米松（Kd）在既往接受过达雷木单抗治疗的患者中的比较：LYNX研究

LEUKEMIA & LYMPHOMA
IF2.2
2025-10-010
PRE
Bahlis, Nizar J.; Zonder, Jeffrey; Karlin, Lionel; Plesner, Torben; Paris, Laura; Wrobel, Tomasz; Hungria, Vania; Besemer, Britta; Crusoe, Edvan; Silkjaer, Trine; Perrot, Aurore; Moreau, Philippe; Wu, Ka Lung; Delimpasi, Sosana; Dimopoulos, Meletios A.; Levin, Mark-David; Mangiacavalli, Silvia; Nnane, Ivo; Kim, Yu Jin; Krevvata, Maria; Sha, Linlin; Wroblewski, Susan; Tuozzo, Alba; Carson, Robin; Facon, Thierry
Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

CASSIOPEIA试验中，新诊断多发性骨髓瘤患者维持治疗前的FDG PET/CT反应的预后价值

Blood
IF23.1
2025-09-260
PRE
Françoise Kraeber-Bodéré; Bastien Jamet; Sonja Zweegman; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj; Emmanuel Itti; Lionel Karlin; Clément Bailly; Mark-David Levin; Monique C. Minnema; Caroline Bodet-Milin; Bart de Keizer; Jill Corre; Pieter Sonneveld; Philippe Moreau; Thomas Carlier; Cyrille Touzeau
Frail subgroups determine heterogeneous outcomes in older patients with NDMM – long-term follow-up of the HOVON 143 trial

脆弱亚组确定了新诊断多发性骨髓瘤老年患者中异质性结局——HOVON 143试验的长期随访

Blood Advances
IF7.1
2025-08-250
OAAI
Febe Smits; Kaz Groen; Mark-David Levin; Claudia A. M. Stege; Roel van Kampen; Ellen van der Spek; Inger Nijhof; Yavuz M. Bilgin; Noortje Thielen; Inge Ludwig; Esther G. M. de Waal; Yorick Sandberg; Alain Kentos; Gert-Jan Timmers; Josien C. Regelink; Matthijs Westerman; Koen de Heer; Marie-Christiane Vekemans; Nazik Durdu-Rayman; Nicole C. H. P. de Graauw
Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial

MRD指导下的伊布替尼联合维奈克拉治疗复发慢性淋巴细胞白血病：VISION/HO141期2临床试验

Blood Advances
IF7.1
2025-04-210
OA
Carsten U. Niemann; Julie Dubois; Kazem Nasserinejad; Caspar da Cunha-Bang; Sabina Kersting; Lisbeth Enggaard; Gerrit J. Veldhuis; Rogier Mous; Clemens H.M. Mellink; Anne-Marie F. van der Kevie-Kersemaekers; Johan A. Dobber; Christian B. Poulsen; Wida Razawy; René Hollestein; Henrik Frederiksen; Ann Janssens; Ida Schjødt; Ellen C. Dompeling; Juha Ranti; Christian Brieghel; Mattias Mattsson; Mar Bellido; Hoa T. T. Tran; Arnon P. Kater; Mark-David Levin
Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

脆弱性亚组确定新诊断多发性骨髓瘤老年患者异质性结局—HOVON 143试验的长期随访

BLOOD
IF23.1
2024-11-051
PRE
Smits, Febe; Groen, Kaz; Levin, Mark-David; Stege, Claudia A. M.; Kampen, Roel J. W. van; van der Spek, Ellen; Bilgin, Yavuz M.; Thielen, Noortje; Nijhof, Inger S.; Ludwig, Inge; Waal, Esther G. M. De; Sandberg, Yorick; Kentos, Alain; Timmers, Gert Jan; Regelink, Josien C.; Westerman, Matthijs; de Heer, Koen; Vekemans, Marie Christiane; Durdu-Rayman, Nazik; de Graauw, Nicole; Seefat, Maarten R.; Donk, Niels W. C. J. van de; Ypma, Paula F.; Nasserinejad, Kazem; Zweegman, Sonja
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes
HEMASPHERE
IF14.6
2024-07-041
OAAI
Groen, Kazimierz; Smits, Febe; Nasserinejad, Kazem; Levin, Mark-David; Regelink, Josien C.; Timmers, Gert-Jan; de Waal, Esther G. M.; Westerman, Matthijs; Velders, Gerjo A.; de Heer, Koen; Leys, Rineke B. L.; van Kampen, Roel J. W.; Stege, Claudia A. M.; Seefat, Maarten R.; Nijhof, Inger S.; van der Spek, Ellen; Klein, Saskia K.; van de Donk, Niels W. C. J.; Ypma, Paula F.; Zweegman, Sonja
Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX
BLOOD ADVANCES
IF7.1
2024-01-122
OAAI
Spencer, Andrew; Moreau, Philippe; Mateos, Maria-Victoria; Goldschmidt, Hartmut; Suzuki, Kenshi; Levin, Mark-David; Sonneveld, Pieter; Orlowski, Robert Z.; Yoon, Sung-Soo; Usmani, Saad Z.; Weisel, Katja; Reece, Donna; Ahmadi, Tahamtan; Pei, Huiling; Mayo, Wendy Garvin; Gai, Xue; Carey, Jodi; Bartlett, J. Blake; Carson, Robin; Dimopoulos, Meletios A.
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究，欧洲CLL研究倡议，和谐

ECLINICALMEDICINE
IF10
2023-11-016
OAAI
Chatzikonstantinou, Thomas; Scarfo, Lydia; Karakatsoulis, Georgios; Minga, Eva; Chamou, Dimitra; Iacoboni, Gloria; Kotaskova, Jana; Demosthenous, Christos; Smolej, Lukas; Mulligan, Stephen; Alcoceba, Miguel; Al-Shemari, Salem; Aurran-Schleinitz, Therese; Bacchiarri, Francesca; Bellido, Mar; Bijou, Fontanet; Calleja, Anne; Medina, Angeles; Khan, Mehreen Ali; Cassin, Ramona; Chatzileontiadou, Sofia; Collado, Rosa; Christian, Amy; Davis, Zadie; Dimou, Maria; Donaldson, David; Dos Santos, Gimena; Dreta, Barbara; Efstathopoulou, Maria; El-Ashwah, Shaimaa; Enrico, Alicia; Fresa, Alberto; Galimberti, Sara; Galitzia, Andrea; Garcia-Serra, Rocio; Gimeno, Eva; Gonzalez-Gascon-Y-Marin, Isabel; Gozzetti, Alessandro; Guarente, Valerio; Guieze, Romain; Gogia, Ajay; Gupta, Ritu; Harrop, Sean; Hatzimichael, Eleftheria; Herishanu, Yair; Hernandez-Rivas, Jose-Angel; Inchiappa, Luca; Jaksic, Ozren; Janssen, Susanne; Kalicinska, Elzbieta; Kamel, Laribi; Karakus, Volkan; Kater, Arnon P.; Kho, Bonnie; Kislova, Maria; Konstantinou, Eliana; Koren-Michowitz, Maya; Kotsianidis, Ioannis; Kreitman, Robert J.; Labrador, Jorge; Lad, Deepesh; Levin, Mark-David; Levy, Ilana; Longval, Thomas; Lopez-Garcia, Alberto; Marquet, Juan; Martin-Rodriguez, Lucia; Maynadie, Marc; Maslejova, Stanislava; Mayor-Bastida, Carlota; Mihaljevic, Biljana; Milosevic, Ivana; Miras, Fatima; Moia, Riccardo; Morawska, Marta; Murru, Roberta; Nath, Uttam Kumar; Navarro-Bailon, Almudena; Oliveira, Ana C.; Olivieri, Jacopo; Oscier, David; Panovska-Stavridis, Irina; Papaioannou, Maria; Papajik, Tomas; Kubova, Zuzana; Phumphukhieo, Punyarat; Pierie, Cheyenne; Puiggros, Anna; Rani, Lata; Reda, Gianluigi; Rigolin, Gian Matteo; Ruchlemer, Rosa; de Deus Santos, Marcos Daniel; Schipani, Mattia; Schiwitza, Annett; Shen, Yandong; Simkovic, Martin; Smirnova, Svetlana; Soliman, Dina Sameh Abdelrahman; Spacek, Martin; Tadmor, Tamar; Tomic, Kristina; Tse, Eric; Vassilakopoulos, Theodoros; Visentin, Andrea; Vitale, Candida; von Tresckow, Julia; Vrachiolias, George; Vukovic, Vojin; Walewska, Renata; Wasik-Szczepanek, Ewa; Xu, Zhenshu; Yagci, Munci; Yanez, Lucrecia; Yassin, Mohamed; Zuchnicka, Jana; Angelopoulou, Maria; Antic, Darko; Biderman, Bella; Catherwood, Mark; Claus, Rainer; Coscia, Marta; Cuneo, Antonio; Demirkan, Fatih; Espinet, Blanca; Gaidano, Gianluca; Kalashnikova, Olga B.; Laurenti, Luca; Nikitin, Eugene; Pangalis, Gerassimos A.; Panagiotidis, Panagiotis; Popov, Viola Maria; Pospisilova, Sarka; Sportoletti, Paolo; Stavroyianni, Niki; Tam, Constantine; Trentin, Livio; Chatzidimitriou, Anastasia; Bosch, Francesc; Doubek, Michael; Ghia, Paolo; Stamatopoulos, Kostas

研究方向

暂未获取到该数据
A
Arnon P. Kater
H 指数:56论文数:528被引数:1.2万
S
Sonja Zweegman
H 指数:87论文数:772被引数:3.2万
E
Ellen van der Spek
H 指数:17论文数:117被引数:1,122
N
Niels W.C.J. van de Donk
H 指数:78论文数:628被引数:2.5万
P
Pieter Sonneveld
H 指数:126论文数:1,252被引数:7.6万
C
Carsten Utoft Niemann
H 指数:48论文数:458被引数:9,766
P
Paula F. Ypma
H 指数:24论文数:123被引数:2,234
M
Monique C. Minnema
H 指数:59论文数:425被引数:1.6万
S
Saskia K. Klein
H 指数:25论文数:134被引数:4,118
K
Kazem Nasserinejad
H 指数:21论文数:104被引数:1,623